News Merck funds Antidote's clinical trial matching tech Funding will go toward expansion of platform capabilities.
Views & Analysis Digital Health Round-up: Microsoft to ‘solve’ cancer and mor... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News FDA clears Sanofi's Type 3 Gaucher therapy Infilbray Sanofi's Infilbray has become the first drug to treat neurological symptoms of rare lysosomal storage disorder Type 3 Gaucher disease (GD3) in the US.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.